Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$0.53 - $0.93 $5,321 - $9,337
10,040 Added 62750.0%
10,056 $5,000
Q1 2022

May 06, 2022

BUY
$2.35 - $3.47 $37 - $55
16 New
16 $0

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.